The specialty biotech company’s Ebitda declined 17 per cent annually to Rs 42 crore, while margins contracted 346 bps to 29 per cent during the quarter
Subscribe To Our Free Newsletter |
The specialty biotech company’s Ebitda declined 17 per cent annually to Rs 42 crore, while margins contracted 346 bps to 29 per cent during the quarter
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!